{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:56:54Z","timestamp":1760425014178,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jneuroim.2010.06.011","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T04:22:36Z","timestamp":1279686156000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease"],"prefix":"10.1016","volume":"226","author":[{"given":"Itzhak","family":"Mendel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oshrat","family":"Propheta-Meiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eti","family":"Ishai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez","family":"Feige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Breitbart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.06.011_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI0215751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12","volume":"110","author":"Becher","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI114562","article-title":"Minimally modified low density lipoprotein stimulates monocyte endothelial interactions","volume":"85","author":"Berliner","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.175.1.501","article-title":"Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40","volume":"175","author":"Bl\u00fcml","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nature01023","article-title":"Protective role of phospholipid oxidation products in endotoxin-induced tissue damage","volume":"419","author":"Bochkov","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.06.011_bib5","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1074\/jbc.275.13.9163","article-title":"The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein","volume":"275","author":"Boullier","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib6","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.4049\/jimmunol.169.11.6554","article-title":"Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody","volume":"169","author":"Brok","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib7","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20031763","article-title":"Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory","volume":"200","author":"Chang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.06.011_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib10","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","article-title":"IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination","volume":"169","author":"Gran","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4049\/jimmunol.140.2.440","article-title":"Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments","volume":"140","author":"Higgins","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.192.7.1075","article-title":"Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2","volume":"192","author":"Izikson","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1344","article-title":"Lipid microarrays identify key mediators of autoimmune brain inflammation","volume":"12","author":"Kanter","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.RES.87.6.516","article-title":"Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells","volume":"87","author":"Lee","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib16","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.171.5.2610","article-title":"Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion","volume":"171","author":"Lucas","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib17","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and anti inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/clinchem\/38.12.2449","article-title":"Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions","volume":"38","author":"Naidoo","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y","article-title":"The macrophage scavenger receptor type A directs modified proteins to antigen presentation","volume":"29","author":"Nicoletti","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib20","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1164\/rccm.200511-1737OC","article-title":"Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury","volume":"173","author":"Nonas","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jnr.21206","article-title":"Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain","volume":"85","author":"Qin","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.187.4.537","article-title":"An interleukin (IL)-10\/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease","volume":"187","author":"Segal","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/eji.200737619","article-title":"Oxidized phospholipids induce anergy in human peripheral blood T cells","volume":"38","author":"Seyerl","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib24","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells","volume":"14","author":"Stromnes","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib27","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.ATV.20.10.2248","article-title":"Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position","volume":"20","author":"Subbanagounder","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib28","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1073\/pnas.96.7.3842","article-title":"Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1","volume":"96","author":"Teitelbaum","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2010.06.011_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:15:34Z","timestamp":1759047334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810002663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165572810002663"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.06.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}